Cite
MLA Citation
E. Van Cutsem et al.. “Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study.” European journal of cancer, vol. 127, 2020, pp. 150–157. http://access.bl.uk/ark:/81055/vdc_100101475659.0x00002b